Skip to main content
Premium Trial:

Request an Annual Quote

So the Amendment Wasn't All That Effective

The Cross-Border Biotech Blog reports that a "comparative effectiveness" amendment introduced to the US budget bill was rejected with a 44-54 vote. This amendment, introduced by Senator Jon Kyl (R-AZ), would have prohibited federal healthcare programs from using data from comparative effectiveness research to deny treatment coverage and made sure that comparative effectiveness research accounts for advances in genomics and personalized medicine as well as treatment response and preference. The blogger, Jeremy Grushcow, adds that it's the first part of the amendment that likely led to its failure and that "ultimately, there may be some treatments that are genuinely less effective than others in comparable populations. As a patient and as a taxpayer, I'd like to know what those are and avoid taking or paying for them."

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.